Navigation Links
Research Shows 10-15% Will Need Periodontal Treatment – Act Now, Warn Eludril and Elgydium

Bournemouth, Dorset (PRWEB) April 23, 2013

New research which shows that 10 to 15 per cent of adults will develop periodontitis has prompted a warning from the manufacturers of Elgydium toothpaste and Eludril mouthwash.

The research – published recently in the National Library of Medicine – highlights the dangers of ignoring the early signs of gum disease (gingivitis).

If left unchecked, gingivitis can worsen and develop into periodontitis, an advanced form of gum disease which can attack bone as well as soft tissue.

Gum disease has far reaching consequences with well documented associations with more serious conditions such as cardiac and respiratory problems, diabetes, some cancers and osteoporosis – as well as dementia and premature birth.

“Gingivitis is serious enough but periodontitis is even more serious and can do lasting damage to the bones of the mouth as well as the gums,” said a spokesperson for Eludril and Elgydium.

“And yet there is no need to suffer with a painful gum condition. Gingivitis and periodontitis are both avoidable. Gum disease is easy to identify and simple to treat if caught early.

“Even if people miss the initial warning signs such as the gum swelling around the teeth, there are other indications which are hard to ignore.”

Blood on the gums can be caused by brushing teeth too vigorously but all too often it is a clear indication of gingivitis.

Gum recession – with or without bleeding – is another serious warning sign that should not be ignored, although this too can be caused by over-enthusiastic or careless brushing.

Regular checks by dental professionals are important in diagnosing the symptoms of gingivitis early – before the condition worsens and develops into periodontitis.

For decades, dentists and hygienists all over the world have recommended chlorhexidine (an important ingredient in both Elgydium and Eludril) as the gold standard treatment for gum disease.

Not only does chlorhexidine treat gingivitis and periodontitis but regular brushing with one of the Elgydium range of antibacterial toothpastes can help to prevent them.

Elgydium is strong enough to kill the bacteria that cause gum disease but can be used daily as part of a normal oral health regime.

Eludril gingivitis mouthwash should be used two or three times daily while symptoms persist. The recommended dosage of Eludril is 10 to 15 ml, diluted with warm water in the measuring cup provided. It is a quick and simple treatment for when gum disease is detected.

Eludril can also be used to disinfect dentures, using a one-in-three dilution with water. The dentures should be cleansed as normal then soaked in the Eludril dilution for around 60 minutes.

For further details about treating periodontitis with Eludril and Elgydium, please contact Chloe Rogers at Ceuta Healthcare on +44 (0)844 243 6661.


Notes For Editors

Eludril and Elgydium are represented in the UK by:

Ceuta Healthcare Ltd
Hill House
41 Richmond Hill
Tel: +44 (0)844 243 6661

Eludril Mouthwash is an antibacterial and analgesic solution which can be used to manage a number of oral health problems.

Its main use is to treat and prevent dental plaque formation and gum disease (gingivitis, also known as periodontitis) by preventing the build-up of bacteria.

Eludril Mouthwash can also be used to maintain oral hygiene in situations where tooth brushing is difficult, for instance, following oral surgery or in physically or mentally handicapped patients.

Eludril can also be used as a disinfectant for the cleansing of removable dentures and in the management of common mouth ulcers and oral candidiasis infections (fungus infections).

Elgydium Anti-Plaque toothpaste is specially formulated for sensitive gums and helps to prevent dental plaque and tartar build-up, the major causes of tooth decay and gum disease.

Elgydium Whitening, Sensitive and Decay Protection are also available as part of the Elgydium range of toothpastes.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Seena Magowitz Foundation donates $500,000 for TGen pancreatic cancer research
2. Researchers identify new pathway, enhancing tamoxifen to tame aggressive breast cancer
3. New research project aims to improve cancer therapies using type I interferons
4. Should kids sit less or move more? CHEO Research answers
5. The Melanoma Research Alliance Foundation supports CNIO research
6. Deficiency in p53 anti-tumor protein delays DNA repair after radiation, Moffitt researchers say
7. Latest research shows 2 items are key to decrease symptoms and prolong survival for LMC patients
8. Wayne State researchers seek calcium channels to target cancer tumors
9. Medical Device Market: Peru & Philippines New Market Research Report Available At
10. Toothpaste and Toothbrush Manufacturing in China Industry Research Report – Now Available from IBISWorld
11. Medical Robotic Systems Market - New Market Research Report Published by Transparency Market Research
Post Your Comments:
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, ... the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where ... city’s history as home to some of the world’s leading providers of cereal and ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women ... diagnosed with endometriosis. These women need a treatment plan to not only alleviate ... that can help for preservation of fertility and ultimately achieving a pregnancy. The ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June 24, ... -based mobile pulmonary function testing company, is now able to perform ... developed by ndd Medical Technologies , Inc. ... in hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ARL ... can get any needed testing done in the comfort of her ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... 2016  In a startling report released today, National Safety ... lacking a comprehensive, proven plan to eliminate prescription opioid overdoses. ... how states are tackling the worst drug crisis in recorded U.S. ... Kentucky , New Mexico , ... Of the 28 failing states, three – Michigan ...
Breaking Medicine Technology: